Showing 21 - 40 results of 203 for search '"Hodgkin lymphoma"', query time: 0.05s Refine Results
  1. 21

    Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma by Marguerite Tyran, Laurence Gonzague, Reda Bouabdallah, Michel Resbeut

    Published 2014-01-01
    “…Localized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. …”
    Get full text
    Article
  2. 22

    HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART by Caron A. Jacobson, Jeremy S. Abramson

    Published 2012-01-01
    “…Patients with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) are at increased risk for developing Hodgkin's lymphoma (HL), a risk that has not decreased despite the success of combination antiretroviral therapy (cART) in the modern era. …”
    Get full text
    Article
  3. 23

    Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas by Claudio Fozza, Maurizio Longinotti

    Published 2011-01-01
    “…The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. …”
    Get full text
    Article
  4. 24
  5. 25

    Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging Problem by Moosa Patel, Vinitha Philip, Fatima Fazel

    Published 2011-01-01
    “…Hodgkin's lymphoma (HL) occurs with increasing frequency in human-immunodeficiency-virus-(HIV-) infected individuals. …”
    Get full text
    Article
  6. 26
  7. 27
  8. 28

    The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients by Evgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, Ilya Kazantsev, Tatjana Zabelina, Francis Ayuk, Axel Rolf Zander

    Published 2011-01-01
    “…Despite the favorable prognosis of most patients with Hodgkin's Lymphoma (HL), 15–20% of patients remain refractory to chemoradiotherapy, and 20–40% experience relapses following autologous stem cell transplantation (SCT) being used as salvage approach in this situation. …”
    Get full text
    Article
  9. 29
  10. 30

    Prognostic Significance of Serum Proangiogenic Molecules in Patients with De Novo Non-Hodgkin Lymphomas by Pairaya Rujirojindakul, Arnuparp Lekhakula

    Published 2012-01-01
    “…Serum VEGF and bFGF concentrations were measured from 79 adult patients with newly diagnosed stage 2–4 non-Hodgkin lymphomas by quantitative sandwich enzyme immunoassay. …”
    Get full text
    Article
  11. 31
  12. 32

    Impact of Methotrexate and 7‐Hydroxymethotrexate Exposure on Renal Toxicity in Pediatric Non‐Hodgkin Lymphoma by Hao Bing, Yi Ma, Jiamin Xu, Qixian Ling, Yanlong Duan, Libo Zhao

    Published 2025-01-01
    “…Method A total of 280 plasma concentration data (140 for MTX and 140 for 7‐OHMTX) for 60 pediatric patients with non‐Hodgkin lymphoma (NHL) were prospectively collected. Plasma MTX and 7‐OHMTX concentrations were determined using a high‐performance liquid chromatography tandem mass spectrometry (HPLC–MS/MS) method. …”
    Get full text
    Article
  13. 33

    Hodgkin Lymphoma and Castleman Disease: When One Blood Disease Can Hide Another by L. Filliatre-Clement, H. Busby-Venner, C. Moulin, G. Roth-Guepin, A. Perrot

    Published 2017-01-01
    “…We describe a rare case of Castleman disease associated de novo with Hodgkin lymphoma. The incidence of Castleman disease is rare; only a few studies have described it in de novo association with Hodgkin lymphoma. …”
    Get full text
    Article
  14. 34

    Ovarian Non-Hodgkin Lymphoma Revealed by Bone Metastasis: A Rare Pediatric Case by M. Elbaz, S. Hiroual, F. Boukis, H. Raiss, A. Matrane, J. Elhoudzi

    Published 2021-01-01
    “…Ovary involvement of non-Hodgkin lymphoma (NHL) is rare. We report a rare case of ovarian NHL during adolescence revealed by bone metastasis. …”
    Get full text
    Article
  15. 35

    Obstructive Jaundice as an Initial Manifestation of Non-Hodgkin Lymphoma: Treatment Dilemma and High Mortality by Dhara Chaudhari, Sarah Khan, Atif Saleem, Tamarro Taylor, Chakradhar Reddy, Thomas Borthwick, Mark Young

    Published 2013-01-01
    “…Introduction. Non Hodgkin lymphoma (NHL) presenting with obstructive jaundice is a rare occurrence. …”
    Get full text
    Article
  16. 36

    Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors by Maansi Joshi, Stephen M. Ansell

    Published 2020-01-01
    “…Non-Hodgkin lymphomas comprise a heterogenous group of disorders which differ in biology. …”
    Get full text
    Article
  17. 37

    Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation by Ádám Jóna, Gábor Irsai, Sándor Barna, Gábor Méhes, Árpád Illés, László Váróczy

    Published 2016-01-01
    “…Introduction. Hodgkin lymphoma is a highly curable lymphoid malignancy; however treatment of a significant number of patients remains challenging. …”
    Get full text
    Article
  18. 38
  19. 39

    A Novel Case of Symptomatic BK Viraemia in a Patient Undergoing Treatment for Hodgkin Lymphoma by Jacinta Perram, Jane Estell

    Published 2014-01-01
    “…The present case describes a novel clinical scenario of symptomatic urological BK virus infection in a patient receiving treatment for Hodgkin lymphoma. This case highlights the importance of casting a wide diagnostic net for adverse events encountered with novel therapeutic agents or regimens.…”
    Get full text
    Article
  20. 40

    Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment by Eleni Thodou, Maria Befani, George Triantafyllidis, Theodosia Choreftaki, George Kanellis, Nikolaos Giannakoulas

    Published 2019-01-01
    “…Extranodal Hodgkin lymphoma involving the breast is infrequent. Most cases reported in the literature were diagnosed by histology after lumpectomy. …”
    Get full text
    Article